Boston Scientific Corp. (BSX) Tops Q2 EPS by 7c; Guides Q3 EPS Below, Reaffirms FY12
Tweet
Share
E-mailGet Alerts BSX Hot Sheet
Price: $51.69 +0.53%
Financial Fact:
Operating expenses: 1.16B
Today's EPS Names:
CMCT, STEX, PWCM, More
Financial Fact:
Operating expenses: 1.16B
Today's EPS Names:
CMCT, STEX, PWCM, More
Join SI Premium – FREE
Boston Scientific Corp. (NYSE: BSX) reported Q2 EPS of $0.17, $0.07 better than the analyst estimate of $0.10. Revenue for the quarter came in at $1.83 billion versus the consensus estimate of $1.89 billion.
Boston Scientific Corp. sees Q3 2012 EPS of $0.14-$0.17, versus the consensus of $0.11. Boston Scientific Corp. sees Q3 2012 revenue of $1.725-$1.825 billion, versus the consensus of $1.83 billion.
Reaffirms FY12 outlook.
For earnings history and earnings-related data on Boston Scientific Corp. (BSX) click here.
Boston Scientific Corp. sees Q3 2012 EPS of $0.14-$0.17, versus the consensus of $0.11. Boston Scientific Corp. sees Q3 2012 revenue of $1.725-$1.825 billion, versus the consensus of $1.83 billion.
Reaffirms FY12 outlook.
For earnings history and earnings-related data on Boston Scientific Corp. (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
